abstract |
The invention relates to (-) - 5- (3-chlorophenyl) -alpha- (4-chlorophenyl) -alpha- (1-methyl-1H-imidazol-5-yl) tetrazolo [1,5-a] quinazolin-7 -methanamine and to its pharmaceutically acceptable acid addition salts, and to the use of these compounds in the medicine, in particular for the treatment of cancer. |